Skip to content

Depression: all studies

Page 936 of 1,034: studies 9,351 to 9,360 of 10,336, newest first. Back to the depression overview

Research

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial

Psychological Medicine August 12, 2015 James W. Murrough, Laili Soleimani, Kaitlin E. DeWilde et al. 297 citations

BACKGROUND: Suicide is a devastating public health problem and very few biological treatments have been found to be effective for quickly reducing the intensity of suicidal ideation (SI). We have previously shown that a single dose of ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, is associated with a rapid reduction in depressive symptom severity and SI in patients with...

DOI: 10.1017/s0033291715001506 (opens in new tab) Anxiety Suicidal ideation Tolerability Randomized controlled trial +6

Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a

Neuron August 5, 2015 Tsvetan Serchov, H. Clement, M. Schwarz et al.

SUMMARY Major depressive disorder is among the most commonly diagnosed disabling mental diseases. Several non-pharmacological treatments of depression upregulate adenosine concentration and/or adenosine A1 receptors (A1R) in the brain. To test whether enhanced A1R signaling mediates antidepressant effects, we generated a transgenic mouse with enhanced doxycycline-regulated A1R expression,...

Nightmares in Patients with Psychosis: The Relation with Sleep, Psychotic, Affective, and Cognitive Symptoms

The Canadian Journal of Psychiatry August 1, 2015 Bryony Sheaves, Juliana Onwumere, Nadine Keen et al. 74 citations

OBJECTIVE: To examine the prevalence of nightmares in people with psychosis and to describe the link between nightmares and sleep quality, psychotic, affective, and cognitive symptoms. METHODS: Forty participants with psychotic symptoms completed an assessment of nightmares, sleep quality, positive symptoms of psychosis, affect, posttraumatic stress, social functioning, and working memory....

LONG-TERM OUTCOME OF MINDFULNESS-BASED COGNITIVE THERAPY IN RECURRENTLY DEPRESSED PATIENTS WITH AND WITHOUT A DEPRESSIVE EPISODE AT BASELINE.

Depression and Anxiety August 2015 Joël R Van Aalderen, A Rogier T Donders, Karlijn Peffer et al.

In a previous randomized controlled trial in patients with three or more previous depressive episodes, mindfulness-based cognitive therapy (MBCT) appeared to be equally effective in those who were depressed and those who were in remission at the start of the trial. The aim of this study is to compare the 1-year outcome of MBCT in 124 remitted and 58 depressed patients who participated in the...

DOI: 10.1002/da.22369 (opens in new tab) Full text (opens in new tab) Long-term outcome Mindfulness-based cognitive therapy Recurrent depressive disorder

Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.

Behavioural Pharmacology August 2015 Michael B. Gatch, Michael J Forster

When synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. Unlike the scheduled cannabinoids, the newer compounds have not been characterized for potency and efficacy in preclinical studies. The purpose of these experiments was to determine whether some of the more recent synthetic...

Mindfulness of the kindness of others: The contemplative practice of Naikan in cultural context.

Transcultural Psychiatry August 1, 2015 Chikako Ozawa-de Silva

Mindfulness in the Buddhist tradition involves a variety of practices, and contemporary secular forms of mindfulness practices, therapies, and interventions can similarly be broadened to include more of these forms. The Japanese practice of Naikan takes one mindfulness practice from the Buddhist tradition--that of recollecting the kindness of others--and asks clients to engage in this practice...

Challenges to the uniqueness of psychotic experience in psychosis: insights on research methodology and intervention.

Shanghai archives of psychiatry August 1, 2015 Linda Cw Lam

Paul Bebbington's recent Special Article on the value of psychosocial epidemiology as a tool for understanding the symptomatology of psychosis provides a fresh perspective on understanding the etiology of schizophrenia and related psychotic conditions. Assessment of psychotic-like experiences in non-clinical populations may help to clarify the role of non-psychotic symptoms such as anxiety and...

DOI: 10.11919/j.issn.1002-0829.215068 (opens in new tab) Full text (opens in new tab) Psychosocial stressors Prodromal psychosis Psychosocial epidemiology Non-psychotic symptoms

Loss of Consciousness Is Associated with Stabilization of Cortical Activity.

Journal of Neuroscience July 29, 2015 Guillermo Solovey, Leandro M Alonso, Toru Yanagawa et al.

What aspects of neuronal activity distinguish the conscious from the unconscious brain? This has been a subject of intense interest and debate since the early days of neurophysiology. However, as any practicing anesthesiologist can attest, it is currently not possible to reliably distinguish a conscious state from an unconscious one on the basis of brain activity. Here we approach this problem...

DOI: 10.1523/jneurosci.4895-14.2015 (opens in new tab) Full text (opens in new tab) Ecog Anesthesia Consciousness Dynamical criticality +2

Antidepressant mechanism of ketamine: perspective from preclinical studies

Frontiers in Neuroscience July 21, 2015 Lisa Scheuing, Chi‐Tso Chiu, Hsiao‐Mei Liao et al. 65 citations

A debilitating mental disorder, major depressive disorder is a leading cause of global disease burden. Existing antidepressant drugs are not adequate for the majority of depressed patients, and large clinical studies have demonstrated their limited efficacy and slow response onset. Growing evidence of low-dose ketamine's rapid and potent antidepressant effects offers strong potential for future...

The Process-Outcome Mindfulness Effects in Trainees (PrOMET) study: protocol of a pragmatic randomized controlled trial.

BMC Psychology July 17, 2015 Johannes Mander, Paula Kröger, Thomas Heidenreich et al.

Background: Mindfulness has its origins in an Eastern Buddhist tradition that is over 2500 years old and can be defined as a specific form of attention that is non-judgmental, purposeful, and focused on the present moment. It has been well established in cognitive-behavior therapy in the last decades, while it has been investigated in manualized group settings such as mindfulness-based stress...

DOI: 10.1186/s40359-015-0082-3 (opens in new tab) Full text (opens in new tab) Mindfulness Randomized controlled trial Therapeutic alliance Multilevel models +1